Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Reuben

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Journal of Virology|May 1, 1997
Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cellsB N Lee, N Ordonez, E J Popek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefitsC H Yang, A M Gonzalez-Angulo, J M Reuben, et al.
BMC Cancer|February 21, 2016
CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancerM Mego, D Cholujova, G Minarik, et al.
BMC Cancer|July 22, 2015
Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancerM Mego, Z Cierna, P Janega, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2009
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancerU De Giorgi, V Valero, E Rohren, et al.
British Journal of Cancer|July 4, 2013
Statin use in primary inflammatory breast cancer: a cohort studyT M Brewer, H Masuda, D D Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2008
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlationsM Cristofanilli, P Morandi, S Krishnamurthy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 4, 2011
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapyA Giordano, M Giuliano, M De Laurentiis, et al.
Journal of Cancer|June 22, 2016
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast CancerM Mego, H Gao, E N Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypesH Masuda, T M Brewer, D D Liu, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Journal of Virology|May 1, 1997
Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cellsB N Lee, N Ordonez, E J Popek, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefitsC H Yang, A M Gonzalez-Angulo, J M Reuben, et al.
BMC Cancer|February 21, 2016
CXCR4-SDF-1 interaction potentially mediates trafficking of circulating tumor cells in primary breast cancerM Mego, D Cholujova, G Minarik, et al.
BMC Cancer|July 22, 2015
Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancerM Mego, Z Cierna, P Janega, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2009
Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancerU De Giorgi, V Valero, E Rohren, et al.
British Journal of Cancer|July 4, 2013
Statin use in primary inflammatory breast cancer: a cohort studyT M Brewer, H Masuda, D D Liu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 3, 2008
Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlationsM Cristofanilli, P Morandi, S Krishnamurthy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 4, 2011
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapyA Giordano, M Giuliano, M De Laurentiis, et al.
Journal of Cancer|June 22, 2016
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast CancerM Mego, H Gao, E N Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Long-term treatment efficacy in primary inflammatory breast cancer by hormonal receptor- and HER2-defined subtypesH Masuda, T M Brewer, D D Liu, et al.
Pageof 8